Skip to main content
. 2018 Apr;6(2):137–143.

Figure 2.

Figure 2

Expression of cyclin D1 in different samples of A (Carboplatin), B (Carboplatin and nano-curcumin), C (Paclitaxel), D (Paclitaxel and nano-curcumin), E (Carboplatin and Paclitaxel), F (Carboplatin, Paclitaxel and nano-curcumin), G (nano-curcumin) in tumor cells, and H (nanocurcumin) in normal cells.